Sabine Neirynck

Author PubWeight™ 12.53^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10.	Nat Biotechnol	2003	2.87
2	A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease.	Clin Gastroenterol Hepatol	2006	2.45
3	Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice.	Gastroenterology	2004	1.99
4	Characterization of ApuB, an extracellular type II amylopullulanase from Bifidobacterium breve UCC2003.	Appl Environ Microbiol	2008	1.38
5	AG013, a mouth rinse formulation of Lactococcus lactis secreting human Trefoil Factor 1, provides a safe and efficacious therapeutic tool for treating oral mucositis.	Oral Oncol	2010	0.98
6	Intracellular accumulation of trehalose protects Lactococcus lactis from freeze-drying damage and bile toxicity and increases gastric acid resistance.	Appl Environ Microbiol	2006	0.84
7	Development of an enteric-coated formulation containing freeze-dried, viable recombinant Lactococcus lactis for the ileal mucosal delivery of human interleukin-10.	Eur J Pharm Biopharm	2005	0.83
8	Paracellular entry of interleukin-10 producing Lactococcus lactis in inflamed intestinal mucosa in mice.	Inflamm Bowel Dis	2008	0.79
9	Evaluation of extrusion/spheronisation, layering and compaction for the preparation of an oral, multi-particulate formulation of viable, hIL-10 producing Lactococcus lactis.	Eur J Pharm Biopharm	2005	0.76